Plunge

Investor Lawsuit Targets BioAge Labs Following Disrupted Drug Trial and Stock Plunge

by

New York — A prominent securities law firm, Bleichmar Fonti & Auld LLP, has recently initiated a lawsuit against BioAge Labs, Inc., a company listed on NASDAQ under the ticker BIOA, along with some of its top executives. The legal action alleges potential breaches of federal securities laws linked to the company’s initial public offering. As part of the case, which is filed under the docket Soto v. BioAge Labs, Inc., et al., No. 25-cv-196, plaintiffs must file their petitions by March 10, 2025, to be considered as lead plaintiffs. The filed complaint highlights issues … Read more

Shareholders Sue Humana for Alleged Misleading Financial Forecasts Amidst Stock Plunge

by

LOUISVILLE, Ky. — A recent class action lawsuit targets Humana Inc., one of America’s leading health insurance providers, alleging that the company misled investors about its financial health and business operations. Filed on June 3, 2024, the suit claims that Humana’s misleading statements led shareholders to purchase stock at inflated prices between July 27, 2022, and January 24, 2024. Investors who acquired shares during this period are now seeking damages, claiming they have suffered significant financial losses following disclosures of higher-than-expected medical costs. The lawsuit opens participation to any affected shareholder looking to recover their … Read more